3rd Generation Packaging System Mix

Cat. No.
LV053
Unit
200µl
Price
$355.00
Cat. No. LV053
Name 3rd Generation Packaging System Mix
Unit 200µl
Description

For the production of lentiviral particles, three components are generally required: 1) a lentiviral vector containing your inserts of interest, 2) one or two packaging vectors which contain all necessary viral structure proteins, 3) an envelope vector expressing Vesicular Stomatitis Virus (VSV) glycoprotein (G).

The 3rd generation packaging system offers maximal biosafety as the lentiviral Rev gene is supplied as an independent vector from other structure genes, further eliminating the possibility of reverse recombination of vectors into replication competent viral particles.

The 3rd generation lentiviral packaging mix will only support lentiviral expression vectors with a chimeric 5' LTR in which the HIV promoter is replaced with CMV or RSV, thus making it TAT-independent. The 3rd generation lentiviral vectors will not support the production of 2nd generation lentiviral particle productions. All of the lentiviral vectors marketed by ABM are TAT-independent.

 

Components (200ul mix of 3 plasmids):

pLenti-P3A

pLenti-P3B

pLenti-P3C

  • Selection: Ampicillin (Bacterial Selection)
  • Amount: 200 μl (100 µg mixture of pLenti-P3A, pLenti-P3B, and pLenti-P3C)
  • Appearance: Liquid
  • Storage: Temperature °20-C or below (shipped at ambient temperature)
  • Shelf Life: Up to 1 year (when at °20-C or below in a frost-free freezer)

 

*User Manual Refer to website for downloadable user manual

Additional Information

Shelf Life: Up to 1 year (when stored at -20°C in a frost-free freezer).

Note

NOT FOR RESALE without prior written consent of ABM. This product is distributed for laboratory research only.

Promotions
 
Bundle up, save more!  These cost-saving bundles combine our best-selling Lentivirus Packaging Mix with reagents for transfection, virus titration, and transduction!
 
.
Material Citation If use of this material results in a scientific publication, please cite the material in the following manner: Applied Biological Materials Inc, Cat. No. LV053
Datasheet
  • Chan, MM et al. "Proteome profile and lentiviral transduction of cultured honey bee (Apis mellifera L.) cells" Insect Mol Biol 19(5):653-8 (2010). DOI: 10.1111/j.1365-2583.2010.01022.x. PubMed: 20546039.
  • Ordelheide, AM et al. "Nor-1, a novel incretin-responsive regulator of insulin genes and insulin secretion" Mol Metab 2(3):243-55 (2013). DOI: 10.1016/j.molmet.2013.06.003. PubMed: 24044104.
  • Kim, D et al. "Peroxisomal dysfunction is associated with up-regulation of apoptotic cell death via miR-223 induction in knee osteoarthritis patients with type 2 diabetes mellitus" Bone 64C:124-131 (2014). DOI: 10.1016/j.bone.2014.04.001. PubMed: 24727161.
  • Kim, D et al. " Two non-coding RNAs, MicroRNA-101 and HOTTIP contribute cartilage integrity by epigenetic and homeotic regulation of integrin-α1" Cell. Signal. 25:2878 - 87 (2013). DOI: 10.1016/j.cellsig.2013.08.034. PubMed: 24018042. Application: Viral Packaging.
  • George, R et al. "A SHORT INTERFERING RNA MOLECULAR BEACON FOR THE ATTENUATION OF MYCOBACTERIAL INFECTION" American Journal of Biochemistry and Biotechnology 10:40-49 (2014). DOI: 10.3844/ajbbsp.2014.40.49. Application: Viral Packaging.
  • Song, J et al. "A long non-coding RNA, GAS5, plays a critical role in the regulation of miR-21 during osteoarthritis" Journal of Orthopaedic Research 32(12):1628-1635 (2014). DOI: 10.1002/jor.22718. PubMed: 25196583.
  • Song, J et al. "MicroRNA-222 regulates MMP-13 via targeting HDAC-4 during osteoarthritis pathogenesis" BBA Clin : (2014). DOI: 10.1016/j.bbacli.2014.11.009. PubMed: 26673737.
  • Morgan, S et al. "β-Agonist-mediated relaxation of airway smooth muscle is protein kinase A-dependent" J Biol Chem 289(33):23065-23075 (2014). DOI: 10.1074/jbc.M114.557652. PubMed: 24973219.
  • Kim, D et al. "Peroxisomal dysfunction is associated with up-regulation of apoptotic cell death via miR-223 induction in knee osteoarthritis patients with type 2 diabetes mellitus" Bone 64:124-131 (2014). DOI: 10.1016/j.bone.2014.04.001. PubMed: 24727161. Application: Viral Packaging.
  • Song, J et al. "miR-370 and miR-373 regulate the pathogenesis of osteoarthritis by modulating one-carbon metabolism via SHMT-2 and MECP-2, respectively" Aging Cell 5:826-837 (2015). DOI: 10.1111/acel.12363. PubMed: 26103880.
  • Song, J et al. "A long non-coding RNA, GAS5, plays a critical role in the regulation of miR-21 during osteoarthritis" J Orthop Res 32(12):1628-1635 (2014). DOI: 10.1002/jor.22718. PubMed: 25196583. Application: Gene Delivery, Lentivirus.
  • Song, J et al. "MicroRNA-222 regulates MMP-13 via targeting HDAC-4 during osteoarthritis pathogenesis" BBA Clin. :79-89 (2015). DOI: 10.1016/j.bbacli.2014.11.009.
  • Song, J et al. "PBMC and exosome-derived Hotair is a critical regulator and potent marker for rheumatoid arthritis" Clin Exp Med. 1:121-126 (2015). DOI: 10.1007/s10238-013-0271-4. PubMed: 24722995.
  • Kang, Y et al. "PCGEM1 stimulates proliferation of osteoarthritic synoviocytes by acting as a sponge for miR-770" J Orthop Res. : (2015). DOI: 10.1002/jor.23046.
  • Rong, H et al. ""Notch signaling suppresses regulatory T cell function in murine experimental autoimmune uveitis "" Immunology 149.4:447-459 (2016). DOI: 10.1111/imm.12663.
  • Wang, J et al. "Radiofrequency hyperthermia-enhanced herpes simplex virus-thymidine kinase/ganciclovir direct intratumoral gene therapy of hepatocellular carcinoma" American Journal of Cancer Research 6.9:2054–2063 (2016). DOI: 10.1080/02656736.2016.1229045. Application: Animal infection.
  • Kang, et al. "PCGEM1 stimulates proliferation of osteoarthritic synoviocytes by acting as a sponge for miR-770" Journal of Orthopaedic Research 34.3:412 (2016). DOI: 10.1002/jor.23046. Application: Lentiviral infection.
  • Jin, G., Li, Y., Zhang, F., Li, P., Zhao, L., Zhou, Y., ... & Yang, X. "Epithelial ovarian cancer: feasibility of image-guided intratumoral radiofrequency hyperthermia-enhanced direct gene therapy" American journal of cancer research 9(2):378 (2019).
  • Omura, H., Liu, F., Shimakami, T., Murai, K., Shirasaki, T., Kitabayashi, J., Funaki, M., Nishikawa, T., Nakai, R., Sumiyadorj, A., Hayashi, T., Yamashita, T., Honda, M., Kaneko, S. "Establishment and Characterization of a New Cell Line Permissive for Hepatitis C Virus Infection" Scientific Reports 9:7943 (2019). DOI: 10.1038/s41598-019-44257-5.
  • Takemoto, K., Kobatake, K., Miura, K., Fukushima, T., Babasaki, T., Miyamoto, S., Sekino, Y., Kitano, H., Goto, K., Ikeda, K., Hieda, K., Hayashi, T., Hinata, N., & Kaminuma, O. (2022). <scp>BACH1</scp> promotes clear cell renal cell carcinoma progression by upregulating oxidative stress‐related tumorigenicity. Cancer Science, 114(2), 436–448. https://doi.org/10.1111/cas.15607
  • Hung, C.-N., Chen, M., DeArmond, D. T., Chiu, C. H.-L., Limboy, C. A., Tan, X., Kusi, M., Chou, C.-W., Lin, L.-L., Zhang, Z., Wang, C.-M., Chen, C.-L., Mitsuya, K., Osmulski, P. A., Gaczynska, M. E., Kirma, N. B., Vadlamudi, R. K., Gibbons, D. L., Warner, S., … Taverna, J. A. (2023). AXL-initiated paracrine activation of pSTAT3 enhances mesenchymal and vasculogenic supportive features of tumor-associated macrophages. Cell Reports, 42(9), 113067. https://doi.org/10.1016/j.celrep.2023.113067
  • Liu, P., Nadeef, S., Serag, M. F., Paytuví-Gallart, A., Abadi, M., Della Valle, F., Radío, S., Roda, X., Dilmé Capó, J., Adroub, S., Hosny El Said, N., Fallatah, B., Celii, M., Messa, G. M., Wang, M., Li, M., Tognini, P., Aguilar-Arnal, L., Habuchi, S., … Orlando, V. (2024). PRC2-EZH1 contributes to circadian gene expression by orchestrating chromatin states and RNA polymerase II complex stability. The EMBO Journal, 43(23), 6052–6075. https://doi.org/10.1038/s44318-024-00267-2
  • Maurin, M., Ranjouri, M., Megino-Luque, C., Newberg, J. Y., Du, D., Martin, K., Miner, R. E., Prater, M. S., Wee, D. K. B., Centeno, B., Pruett-Miller, S. M., Stewart, P., Fleming, J. B., Yu, X., Bravo-Cordero, J. J., Guccione, E., Black, M. A., & Mann, K. M. (2023). RBFOX2 deregulation promotes pancreatic cancer progression and metastasis through alternative splicing. Nature Communications, 14(1). https://doi.org/10.1038/s41467-023-44126-w
  • Ryplida, B., Kim, D., Jin, E.-J., & Park, S. Y. (2023). Coenzyme a-responsive hydrogel sensor for wireless monitoring and treatment of osteoarthritis. Chemical Engineering Journal, 476, 146479. https://doi.org/10.1016/j.cej.2023.146479
  • Yang, L., Pham, K., Xi, Y., Wu, Q., Liu, D., Robertson, K., & Liu, C. (2024). Exploring Glypican-3 Targeted CAR-NK Treatment and Potential Therapy Resistance in Hepatocellular Carcinoma. https://doi.org/10.22541/au.170664301.11370201/v1
  • Shirasaki, T., González-López, O., McKnight, K. L., Xie, L., Shiota, T., Chen, X., Feng, H., & Lemon, S. M. (2022). Nonlytic Quasi-Enveloped Hepatovirus Release Is Facilitated by pX Protein Interaction with the E3 Ubiquitin Ligase ITCH. Journal of Virology, 96(21). https://doi.org/10.1128/jvi.01195-22
  • Lai, T. H., Ahmed, M., Hwang, J. S., Zada, S., Pham, T. M., Elashkar, O., & Kim, D. R. (2021). Transcriptional Repression of Raf Kinase Inhibitory Protein Gene by Metadherin during Cancer Progression. International Journal of Molecular Sciences, 22(6), 3052–3052. https://doi.org/10.3390/ijms22063052
  • Chan, C.-H., Chiou, L.-W., Lee, T.-Y., Liu, Y.-R., Hsieh, T.-H., Yang, C.-Y., & Jeng, Y.-M. (2022). PAK and PI3K pathway activation confers resistance to KRASG12C inhibitor sotorasib. British Journal of Cancer, 128(1), 148–159. https://doi.org/10.1038/s41416-022-02032-w
  • Chou, C.-W., Hung, C.-N., Chiu, C. H.-L., Tan, X., Chen, M., Chen, C.-C., Saeed, M., Hsu, C.-W., Liss, M. A., Wang, C.-M., Lai, Z., Alvarez, N., Osmulski, P. A., Gaczynska, M. E., Lin, L.-L., Ortega, V., Kirma, N. B., Xu, K., Liu, Z., … Huang, T. H.-M. (2023). Phagocytosis-initiated tumor hybrid cells acquire a c-Myc-mediated quasi-polarization state for immunoevasion and distant dissemination. Nature Communications, 14(1). https://doi.org/10.1038/s41467-023-42303-5
  • Suzuki, H., Nagase, S., Saito, C., Takatsuka, A., Nagata, M., Honda, K., Kaneda, Y., Nishiya, Y., Honda, T., Ishizaka, T., Nakamura, K., Nakada, T., Abe, Y., & Agatsuma, T. (2024). Data from Raludotatug Deruxtecan, a CDH6-Targeting Antibody–Drug Conjugate with a DNA Topoisomerase I Inhibitor DXd, Is Efficacious in Human Ovarian and Kidney Cancer Models. https://doi.org/10.1158/1535-7163.c.7104454.v1
This product has no review yet.
Controls and Related Product:

CAT.NO
LV900
UNIT
100 rxn
PRICE
$212.00

CAT.NO
LV003
UNIT
200µl
PRICE
$293.00

CAT.NO
LV999
UNIT
100 ml
PRICE
$162.00

CAT.NO
G516
UNIT
1.0 ml
PRICE
$190.00

CAT.NO
G515
UNIT
1.0 ml
PRICE
$190.00

CAT.NO
LV998
UNIT
1 kit
PRICE
$567.00